US20080196730A1 - Smokeless Tobacco Product - Google Patents

Smokeless Tobacco Product Download PDF

Info

Publication number
US20080196730A1
US20080196730A1 US11/571,477 US57147705A US2008196730A1 US 20080196730 A1 US20080196730 A1 US 20080196730A1 US 57147705 A US57147705 A US 57147705A US 2008196730 A1 US2008196730 A1 US 2008196730A1
Authority
US
United States
Prior art keywords
vehicle
smokeless tobacco
tobacco product
product according
tobacco
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/571,477
Inventor
Thomas Engstrom
Torbjorn Mathisen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novus Scientific AB
Original Assignee
Radi Medical Systems AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35783173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20080196730(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE0401721A external-priority patent/SE0401721D0/en
Application filed by Radi Medical Systems AB filed Critical Radi Medical Systems AB
Priority to US11/571,477 priority Critical patent/US20080196730A1/en
Assigned to RADI MEDICAL SYSTEMS AB reassignment RADI MEDICAL SYSTEMS AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ENGSTROM, THOMAS, MATHISEN, TORBJORN
Assigned to RADI MEDICAL BIODEGRADABLE AB reassignment RADI MEDICAL BIODEGRADABLE AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RADI MEDICAL SYSTEMS AB
Publication of US20080196730A1 publication Critical patent/US20080196730A1/en
Assigned to IDAR MEDICAL BIODEGRADABLE AB reassignment IDAR MEDICAL BIODEGRADABLE AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: RADI MEDICAL BIODEGRADABLE AB
Assigned to NOVUS SCIENTIFIC PTE. LTD. reassignment NOVUS SCIENTIFIC PTE. LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IDAR MEDICAL BIODEGRADABLE AB
Assigned to NOVUS SCIENTIFIC AB reassignment NOVUS SCIENTIFIC AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: NOVUS SCIENTIFIC PTE. LTD.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Definitions

  • the present invention relates generally to a smokeless tobacco product in the form of a completely dissolvable vehicle comprising concentrated tobacco extract contained in a dissolvable matrix.
  • Smokeless tobacco e.g. so called “snuff”
  • smokeless tobacco is widely used as substitute for cigarettes, cigars and other forms of smoking-tobacco as it poses comparatively less health risks to the user.
  • Many people do also use a smokeless alternative during a transition period to reduce the acute abstinence from nicotine that may results from a sudden refraining from cigarettes.
  • the general object of the present invention is to provide a more appealing administration form for smokeless tobacco.
  • Another object of the invention is to provide a vehicle that, in the mouth of a user, releases flavours coming from tobacco extracts as well as other substances, which vehicle provides for a controlled release and thereby intake of these flavours and substances.
  • a further object is to provide a three-dimensional vehicle which in the mouth of a user creates a three-dimensional sensation.
  • the dissolvable vehicle comprising a water-soluble polymer matrix in which tobacco extract has been incorporated.
  • the tobacco extract has been freed from any type of insoluble residue, and the whole vehicle will therefore dissolve within the mouth of a user.
  • the necessity of an unpleasant and discomfortable removal of a saliva-soaked tobacco pouch is thereby eliminated.
  • the dissolvable vehicle is a three-dimensional vehicle, which in the mouth of a user creates a three-dimensional sensation.
  • the dissolvable three-dimensional vehicle has a multilayer structure, with at least one layer comprising a water-soluble polymer matrix in which concentrated tobacco extract has been incorporated.
  • Another layer of the three-dimensional vehicle may comprise different kinds of flavours, additives, and other drugs such as nicotine.
  • a multilayered three-dimensional vehicle is adapted to dissolve layer by layer, thereby providing for a controlled release and subsequent intake of the drugs and flavours contained in the respective layers.
  • FIG. 1 is a schematic illustration of a first embodiment of the present invention.
  • FIG. 2 is a schematic illustration of a second embodiment of the present invention.
  • FIG. 3 illustrates schematically the dimensions of a vehicle according to one embodiment of the present invention.
  • the present invention relates to a smokeless tobacco product in the form of a dissolvable vehicle comprising a water-soluble polymer matrix containing concentrated tobacco extract.
  • the polymer matrix is made from any type of water-soluble polymer, including both synthetic and naturally occurring polymeric substances.
  • the matrix is formulated to optimize the leaching process of the various flavour substances found in tobacco extracts.
  • the dissolvable vehicle is a body with significant extensions in all three dimensions, such that the dissolvable vehicle at the start of the dissolution process creates a three-dimensional feeling in a user's mouth.
  • suitable water-soluble polymers are various proteins such as collagen or fibrin, and various carbohydrates like alginates, guar gum, agarose, as well as various types of glucosamino-glucanes and cellulose. It can be noted that most of these carbohydrates can be chemically substituted to significantly alter their properties.
  • Various types of polymeric alcohols such as polyethylene glycols, polypropylene glycols, and polyvinyl alcohols, can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers.
  • polyethylene glycols polypropylene glycols
  • polyvinyl alcohols can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers.
  • Several of the alternatives listed above can be cross-linked in various degrees to achieve alterations in their dissolution properties. It is further possible to incorporate various types of non-ionic, cationic and/or anionic substituents in the polymer matrix to
  • the dissolvable vehicle may be a multilayer vehicle.
  • one of the layers preferably the outermost layer, can comprise a component with a certain degree of mucoadhesive properties.
  • An example of such a mucoadhesive substance is chitosan.
  • a mucoadhesive layer would adhere to the mucosa in the mouth of a user, and thereby act as a fixation for the vehicle.
  • Such a mucoadhesive substance could also promote the penetration of tobacco flavours into the mucosa.
  • soluble or “dissolvable” are meant to encompass all types of disintegrating, dissolving, resorbing, absorbing and eroding processes that can occur in a vehicle that in a user's mouth dissolves in such a way that a removal from the mouth and a subsequent disposal of a vehicle rest by hand are not necessary after the tobacco flavours have been extracted.
  • the different substances mentioned above are therefore merely illustrative examples of various ingredients that could be used to formulate a self-disintegrating matrix that constitute a base for a dissolvable vehicle for a smokeless tobacco product.
  • the smokeless tobacco product of the present invention is based on concentrated tobacco extract, which can be extracted by several methods well-known in the art.
  • Tobacco extract is perhaps most easily prepared by treating tobacco with water, or water containing a small amount of an organic solvent.
  • the preferred temperature for extraction is room temperature, but any temperature in the range of 10° C. to 60° C. will work.
  • the pH-value and ionic strength can be adjusted to depress or promote extraction of certain tobacco substances.
  • Supercritical carbon dioxide has, for example, been successfully employed to produce tobacco extracts that are diminished in nicotine.
  • the tobacco extract may include extracts from all original substances of the tobacco plant or a subset thereof, including one or many original substance(s).
  • the tobacco extract may be a synthetically prepared substance having essentially equivalent characteristics as the corresponding extract from the tobacco plant.
  • the extract may include both one or many original (natural) substance(s) and one or many synthetic substance(s).
  • the tobacco extract is nicotine or synthetically prepared nicotine, being the only substance or used in combination with other substances.
  • FIG. 1 illustrates a first and basic embodiment of a smokeless tobacco product according to the present invention.
  • the tobacco product comprises a vehicle 1 , which is made from a water-soluble polymeric matrix in which tobacco extract has been included.
  • the polymeric matrix can be made from any of the polymers listed above.
  • One way to formulate such a tobacco-containing polymeric matrix would be to dissolve one or several suitable polymers in a water-solution of tobacco extracts. The solution is then dried to a suitable matrix form. During the drying process the polymers can optionally be cross-linked to alter their dissolution properties.
  • a polymer material to be used in the present invention should preferably be soft; it could, for example, have a compression modulus less than 0.1 MPa.
  • the polymer material can have a dissolution time ranging from about 5 minutes to about 60 minutes, and preferably from approximately 10 minutes to approximately 30 minutes.
  • FIG. 2 a second embodiment of a vehicle 11 for a smokeless tobacco product is shown.
  • the vehicle 11 is a multi-layer vehicle that comprises an inner layer 12 , an intermediate layer 13 , and an outer layer 14 .
  • the inner layer 12 comprises a water-soluble polymeric matrix in which tobacco extract has been included.
  • the matrix can be formulated in the same way as suggested in conjunction with FIG. 1 , or the polymeric matrix can be in the form of a porous or fibrous matrix in which dry tobacco extract or water-dissolved tobacco extract is incorporated.
  • the intermediate layer 13 can then serve as a cover or seal that encapsulates the tobacco extract inside the polymeric matrix.
  • the intermediate layer 13 can further comprise a swelling substance that absorbs saliva and thereby increases the volume of the vehicle 11 . Any type of cross-linked carbohydrates could be used as a swelling substance.
  • the outer layer 14 can comprise an adhesive, such as chitosan, which adhere to the mucosa in a user's mouth, and thereby fixates the vehicle 11 inside the user's mouth.
  • the outer layer 14 can also comprise a substance that facilitates the penetration of the flavours and other drugs and substances into the mucosa.
  • the structure of the vehicle 11 is only exemplifying, and it should in particular be recognized that more layers could be added, and that the contents of each layer could be altered such that, for example, the swelling substance is in the innermost layer, while the tobacco extract is contained in an intermediate layer.
  • the different layers can be based on the same polymer matrix, the only difference being that different additives, such as drugs and flavours, are included in the different layers, with at least one layer containing the tobacco extract.
  • Another possibility is to prepare a special polymeric matrix for each layer to thereby make it easy to control the dissolution of the layer and the release of substances therefrom.
  • one layer e.g. the outermost layer, in the form of a dragée, which further can comprise a substance which renders this layer a special effect on the user.
  • An advantage of having a multilayer vehicle is that the separate layers can be adapted to dissolve sequentially in a user's mouth.
  • on outer layer is essentially disintegrated before an inner layer starts to dissolve. It is thereby easy to control the effect that the present vehicle has on a user.
  • the outermost layer could include a high concentration of nicotine, as the desire for nicotine presumably is at the highest just after the user has put the vehicle in his or her mouth, while a more interior layer could include a lower concentration of nicotine, when the user's urge for nicotine has been almost satisfied. The total intake of nicotine could thereby be reduced.
  • the present invention is not restricted to any particular dimensions of a vehicle for a smokeless tobacco product.
  • the vehicle can, for example, be in the form of an essentially two-dimensional structure such as a thin sheet or patch. It is, however, the present inventors' belief that for some people it is important that a smokeless tobacco product for oral administration is capable of creating a three-dimensional sensation in the mouth of a user.
  • the term “three-dimensional” is defined as a dimensional relationship that creates a three-dimensional sensation in a user's mouth.
  • the vehicle for the tobacco extract has therefore a first dimension (e.g. a length), a second dimension (e.g. a width) and a third dimensions (e.g. a height), and is characterized in that none of the three dimensions is negligible in comparison with one of the other two dimensions.
  • a first dimension e.g. a length
  • a second dimension e.g. a width
  • a third dimensions e.g. a height
  • FIG. 3 shows a schematic view of the vehicle according to the present invention.
  • A is about 30 mm
  • B is about 15 mm
  • C is about 5 mm, such that C/A ⁇ 1 ⁇ 6.
  • a vehicle according to the present invention is pillowshaped, and provided with rounded corners and/or edges, as can be seen in FIG. 1 or FIG. 2 .
  • the three-dimensional sensation referred to above relates to a three-dimensional sensation created when the vehicle has been placed in the mouth of a user.
  • the vehicle can be essentially two-dimensional before it is placed in the user's mouth. This would in particular apply to a vehicle comprising a swelling substance. Such a vehicle would then perhaps not fulfil the above criteria for A, B and C before it has been placed in the mouth, but would fulfil these criteria shortly after it has come into contact with salvia. Also such vehicles are considered to be three-dimensional vehicles.
  • a vehicle containing tobacco extract can comprise a large variety of different drugs.
  • a drug is nicotine, which can be included in different, selectable concentrations in different versions of the smokeless tobacco product of the present invention.
  • the nicotine concentration could, for example, range from a high concentration to zero, such that people, e.g. inveterate smokers, gradually can reduce their daily intake and finally get rid of their nicotine addiction.
  • the smokeless tobacco product could also be flavoured with extra flavours, such as liquorice, menthol, spearmint or peppermint. It is also possible to add vitamins and minerals to create a healthier product. More dedicated drugs could also be added. Examples of such drugs would be flour or a suitable teeth-whitening substance, or a substance that cures halitosis, or some other type of nature-cure drug.

Abstract

The present invention relates generally to a smokeless tobacco product in the form of a completely dissolvable vehicle (1; 11) comprising concentrated tobacco extract contained in a dissolvable matrix. In one embodiment, the vehicle (11) is a multilayer three-dimensional vehicle whose several layers (12, 13, 14) dissolve layer by layer in the mouth of a user.

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to a smokeless tobacco product in the form of a completely dissolvable vehicle comprising concentrated tobacco extract contained in a dissolvable matrix.
  • BACKGROUND OF THE INVENTION
  • Smokeless tobacco, e.g. so called “snuff”, is widely used as substitute for cigarettes, cigars and other forms of smoking-tobacco as it poses comparatively less health risks to the user. Many people do also use a smokeless alternative during a transition period to reduce the acute abstinence from nicotine that may results from a sudden refraining from cigarettes.
  • To make such tobacco more user-friendly, it is known to confine the tobacco in a small non-dissolvable, permeable pouch, which is kept in the mouth until the tobacco flavours have been extracted from the tobacco and which is then removed. It is, however, also well-known that many people find the use of such tobacco pouches little appealing or even repulsive, mainly because of the necessity to remove the saliva soaked and soggy tobacco pouch from the mouth and then dispose the same. The discomfort is, of course, even more pronounced if the smokeless tobacco is used in a public environment, such as meeting rooms, restaurants or other restricted areas, where it can be difficult or even impossible to dispose the used tobacco pouch in a discreet and hygienic way. Needless to say, these people are even less appealed by smokeless tobacco that is not contained in such a pouch.
  • For the mucosal administration of drugs such as nicotine, drug delivering vehicles in the forms of membranes or patches are known. When such membranes or patches are used for the oral administration of drugs, they do not, however, create a three-dimensional sensation in the user's mouth. It is the present inventors' belief that such a three-dimensional sensation is crucial for some people's acceptance of smokeless tobacco products.
  • A more appealing smokeless tobacco product is therefore needed.
  • SUMMARY OF THE INVENTION
  • Today smokeless tobacco is sold in the form of non-dissolvable tobacco-filled permeable pouches, which a user keeps in his or her mouth until the flavours have been extracted from the tobacco and which the user then removes with his/her fingers, something that many people find unappealing.
  • The general object of the present invention is to provide a more appealing administration form for smokeless tobacco.
  • Another object of the invention is to provide a vehicle that, in the mouth of a user, releases flavours coming from tobacco extracts as well as other substances, which vehicle provides for a controlled release and thereby intake of these flavours and substances.
  • A further object is to provide a three-dimensional vehicle which in the mouth of a user creates a three-dimensional sensation.
  • These objects are achieved with a dissolvable vehicle comprising a water-soluble polymer matrix in which tobacco extract has been incorporated. The tobacco extract has been freed from any type of insoluble residue, and the whole vehicle will therefore dissolve within the mouth of a user. The necessity of an unpleasant and discomfortable removal of a saliva-soaked tobacco pouch is thereby eliminated. In one embodiment of the invention, the dissolvable vehicle is a three-dimensional vehicle, which in the mouth of a user creates a three-dimensional sensation.
  • According to a preferred embodiment of the present invention, the dissolvable three-dimensional vehicle has a multilayer structure, with at least one layer comprising a water-soluble polymer matrix in which concentrated tobacco extract has been incorporated. Another layer of the three-dimensional vehicle may comprise different kinds of flavours, additives, and other drugs such as nicotine. In one embodiment of the invention, a multilayered three-dimensional vehicle is adapted to dissolve layer by layer, thereby providing for a controlled release and subsequent intake of the drugs and flavours contained in the respective layers.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a schematic illustration of a first embodiment of the present invention.
  • FIG. 2 is a schematic illustration of a second embodiment of the present invention.
  • FIG. 3 illustrates schematically the dimensions of a vehicle according to one embodiment of the present invention.
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • The present invention relates to a smokeless tobacco product in the form of a dissolvable vehicle comprising a water-soluble polymer matrix containing concentrated tobacco extract. The polymer matrix is made from any type of water-soluble polymer, including both synthetic and naturally occurring polymeric substances. The matrix is formulated to optimize the leaching process of the various flavour substances found in tobacco extracts. In one embodiment of the invention, the dissolvable vehicle is a body with significant extensions in all three dimensions, such that the dissolvable vehicle at the start of the dissolution process creates a three-dimensional feeling in a user's mouth.
  • Examples of suitable water-soluble polymers are various proteins such as collagen or fibrin, and various carbohydrates like alginates, guar gum, agarose, as well as various types of glucosamino-glucanes and cellulose. It can be noted that most of these carbohydrates can be chemically substituted to significantly alter their properties. Various types of polymeric alcohols, such as polyethylene glycols, polypropylene glycols, and polyvinyl alcohols, can be used to formulate the water-soluble matrix as well as polypyrollidone, and various polymeric acrylic acids and ionomers. Several of the alternatives listed above can be cross-linked in various degrees to achieve alterations in their dissolution properties. It is further possible to incorporate various types of non-ionic, cationic and/or anionic substituents in the polymer matrix to yield satisfying dissolution properties, and also to accelerate or retard the leaching process of a specific tobacco flavour.
  • As already indicated above, the dissolvable vehicle may be a multilayer vehicle. In that case, one of the layers, preferably the outermost layer, can comprise a component with a certain degree of mucoadhesive properties. An example of such a mucoadhesive substance is chitosan. A mucoadhesive layer would adhere to the mucosa in the mouth of a user, and thereby act as a fixation for the vehicle. Such a mucoadhesive substance could also promote the penetration of tobacco flavours into the mucosa.
  • As used herein, the terms “soluble” or “dissolvable” are meant to encompass all types of disintegrating, dissolving, resorbing, absorbing and eroding processes that can occur in a vehicle that in a user's mouth dissolves in such a way that a removal from the mouth and a subsequent disposal of a vehicle rest by hand are not necessary after the tobacco flavours have been extracted. The different substances mentioned above are therefore merely illustrative examples of various ingredients that could be used to formulate a self-disintegrating matrix that constitute a base for a dissolvable vehicle for a smokeless tobacco product.
  • The smokeless tobacco product of the present invention is based on concentrated tobacco extract, which can be extracted by several methods well-known in the art. Tobacco extract is perhaps most easily prepared by treating tobacco with water, or water containing a small amount of an organic solvent. The preferred temperature for extraction is room temperature, but any temperature in the range of 10° C. to 60° C. will work. Also the pH-value and ionic strength can be adjusted to depress or promote extraction of certain tobacco substances. Supercritical carbon dioxide has, for example, been successfully employed to produce tobacco extracts that are diminished in nicotine.
  • The tobacco extract may include extracts from all original substances of the tobacco plant or a subset thereof, including one or many original substance(s). In addition, and within the scope of the present invention as it is defined by the claims, the tobacco extract may be a synthetically prepared substance having essentially equivalent characteristics as the corresponding extract from the tobacco plant. Naturally, the extract may include both one or many original (natural) substance(s) and one or many synthetic substance(s).
  • According to a preferred embodiment the tobacco extract is nicotine or synthetically prepared nicotine, being the only substance or used in combination with other substances.
  • Below exemplifying embodiments of a vehicle for a smokeless tobacco product are described with reference to the accompanying drawings.
  • FIG. 1 illustrates a first and basic embodiment of a smokeless tobacco product according to the present invention. The tobacco product comprises a vehicle 1, which is made from a water-soluble polymeric matrix in which tobacco extract has been included. The polymeric matrix can be made from any of the polymers listed above. One way to formulate such a tobacco-containing polymeric matrix would be to dissolve one or several suitable polymers in a water-solution of tobacco extracts. The solution is then dried to a suitable matrix form. During the drying process the polymers can optionally be cross-linked to alter their dissolution properties. A polymer material to be used in the present invention should preferably be soft; it could, for example, have a compression modulus less than 0.1 MPa. The polymer material can have a dissolution time ranging from about 5 minutes to about 60 minutes, and preferably from approximately 10 minutes to approximately 30 minutes. In FIG. 2, a second embodiment of a vehicle 11 for a smokeless tobacco product is shown. In this embodiment, the vehicle 11 is a multi-layer vehicle that comprises an inner layer 12, an intermediate layer 13, and an outer layer 14. Here, the inner layer 12 comprises a water-soluble polymeric matrix in which tobacco extract has been included. The matrix can be formulated in the same way as suggested in conjunction with FIG. 1, or the polymeric matrix can be in the form of a porous or fibrous matrix in which dry tobacco extract or water-dissolved tobacco extract is incorporated. The intermediate layer 13 can then serve as a cover or seal that encapsulates the tobacco extract inside the polymeric matrix. The intermediate layer 13 can further comprise a swelling substance that absorbs saliva and thereby increases the volume of the vehicle 11. Any type of cross-linked carbohydrates could be used as a swelling substance. The outer layer 14 can comprise an adhesive, such as chitosan, which adhere to the mucosa in a user's mouth, and thereby fixates the vehicle 11 inside the user's mouth. The outer layer 14 can also comprise a substance that facilitates the penetration of the flavours and other drugs and substances into the mucosa. The structure of the vehicle 11 is only exemplifying, and it should in particular be recognized that more layers could be added, and that the contents of each layer could be altered such that, for example, the swelling substance is in the innermost layer, while the tobacco extract is contained in an intermediate layer.
  • When the vehicle is a multilayer vehicle, the different layers can be based on the same polymer matrix, the only difference being that different additives, such as drugs and flavours, are included in the different layers, with at least one layer containing the tobacco extract. Another possibility is to prepare a special polymeric matrix for each layer to thereby make it easy to control the dissolution of the layer and the release of substances therefrom. It is also conceivable to apply one layer, e.g. the outermost layer, in the form of a dragée, which further can comprise a substance which renders this layer a special effect on the user.
  • An advantage of having a multilayer vehicle is that the separate layers can be adapted to dissolve sequentially in a user's mouth. In other words, on outer layer is essentially disintegrated before an inner layer starts to dissolve. It is thereby easy to control the effect that the present vehicle has on a user. As an example, the outermost layer could include a high concentration of nicotine, as the desire for nicotine presumably is at the highest just after the user has put the vehicle in his or her mouth, while a more interior layer could include a lower concentration of nicotine, when the user's urge for nicotine has been almost satisfied. The total intake of nicotine could thereby be reduced.
  • The present invention is not restricted to any particular dimensions of a vehicle for a smokeless tobacco product. The vehicle can, for example, be in the form of an essentially two-dimensional structure such as a thin sheet or patch. It is, however, the present inventors' belief that for some people it is important that a smokeless tobacco product for oral administration is capable of creating a three-dimensional sensation in the mouth of a user. As used herein, the term “three-dimensional” is defined as a dimensional relationship that creates a three-dimensional sensation in a user's mouth.
  • As an example, most of the plasters and patches known in the prior art do not fulfil this criterion. In one embodiment of the present invention, the vehicle for the tobacco extract has therefore a first dimension (e.g. a length), a second dimension (e.g. a width) and a third dimensions (e.g. a height), and is characterized in that none of the three dimensions is negligible in comparison with one of the other two dimensions. When such a vehicle is placed in a user's mouth, the user will experience a sensation that the vehicle occupies space in all three dimensions. When, for example, placed between a lip and teeth or gums, the vehicle would slightly stretch the user's lip to provide essentially the same sensation that is created by a conventional tobacco pouch.
  • If a vehicle for the mucosal administration of tobacco extracts has a length denoted by A, a width denoted by B, and a height denoted by C, and if A is larger than (or equal to) B, then C should be at least one tenth of A (i.e. C/A≧ 1/10), preferably C/A≧ 1/7. A suitable interval for C/A could be ⅛≦C/A≦½. FIG. 3 shows a schematic view of the vehicle according to the present invention.
  • In one embodiment A is about 30 mm, B is about 15 mm, and C is about 5 mm, such that C/A≈⅙. Preferably, a vehicle according to the present invention is pillowshaped, and provided with rounded corners and/or edges, as can be seen in FIG. 1 or FIG. 2.
  • Here it can be noted that the three-dimensional sensation referred to above relates to a three-dimensional sensation created when the vehicle has been placed in the mouth of a user. In other words, the vehicle can be essentially two-dimensional before it is placed in the user's mouth. This would in particular apply to a vehicle comprising a swelling substance. Such a vehicle would then perhaps not fulfil the above criteria for A, B and C before it has been placed in the mouth, but would fulfil these criteria shortly after it has come into contact with salvia. Also such vehicles are considered to be three-dimensional vehicles.
  • Although the present invention has been described with reference to specific embodiments, also shown in the appended drawings, it will be apparent for those skilled in the art that many variations and modifications can be done within the scope of the invention as described in the specification and defined with reference to the claims below. It should in particular be recognized that a vehicle containing tobacco extract can comprise a large variety of different drugs. One example of such a drug is nicotine, which can be included in different, selectable concentrations in different versions of the smokeless tobacco product of the present invention. The nicotine concentration could, for example, range from a high concentration to zero, such that people, e.g. inveterate smokers, gradually can reduce their daily intake and finally get rid of their nicotine addiction. The smokeless tobacco product could also be flavoured with extra flavours, such as liquorice, menthol, spearmint or peppermint. It is also possible to add vitamins and minerals to create a healthier product. More dedicated drugs could also be added. Examples of such drugs would be flour or a suitable teeth-whitening substance, or a substance that cures halitosis, or some other type of nature-cure drug.

Claims (14)

1. Smokeless tobacco product in the form of a dissolvable vehicle (1; 11) for oral administration, said vehicle being characterized in that the vehicle comprises a dissolvable polymeric matrix in which tobacco extract, or a synthetic equivalent thereof, is included.
2. Smokeless tobacco product according to claim 1, characterized in that the dissolvable vehicle is a multilayer vehicle (11) and that said dissolvable polymeric matrix constitutes at least one of the several layers (12, 13, 14).
3. Smokeless tobacco product according to claim 1, characterized in that the tobacco extract is dried tobacco extract.
4. Smokeless tobacco product according to claim 2, characterized in that the outermost layer comprises a mucoadhesive substance.
5. Smokeless tobacco product according to claim 2, characterized in that at least one layer comprises a substance that swells upon contact with saliva.
6. Smokeless tobacco product according to claim 2, characterized in that the multilayer vehicle essentially dissolves layer by layer in a user's mouth.
7. Smokeless tobacco product according to claim 1, characterized in that the vehicle has an essentially two-dimensional shape.
8. Smokeless tobacco product according to claim 1, characterized in the vehicle is, or when placed in a user's mouth swells to, a three dimensional vehicle, which has a first dimension A, a second dimension B and a third dimension C, with A≧B≧C and C/A≧ 1/10.
9. Smokeless tobacco product according to claim 8, characterized in that ⅛≦C/A≦ 2/3.
10. Smokeless tobacco product according to claim 8, characterized in that 1/7≦C/A≦½.
11. Smokeless tobacco product according to claim 1, characterized in that said vehicle has a compression modulus less than 0.1 MPa.
12. Smokeless tobacco product according to claim 1, characterized in that said vehicle has a dissolution time in the interval of 5 to 60 minutes, preferably in the interval of 10 to 30 minutes.
13. Smokeless tobacco product according to claim 1 characterized in that said extract is free from nicotine.
14. Smokeless tobacco product according to claim 1, characterized in that said extract is nicotine or synthetically prepared nicotine.
US11/571,477 2004-07-02 2005-06-08 Smokeless Tobacco Product Abandoned US20080196730A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/571,477 US20080196730A1 (en) 2004-07-02 2005-06-08 Smokeless Tobacco Product

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58449404P 2004-07-02 2004-07-02
SE0401721-674 2004-07-02
SE0401721A SE0401721D0 (en) 2004-07-02 2004-07-02 Drug releasing three-dimensional vehicle
PCT/SE2005/000864 WO2006004480A1 (en) 2004-07-02 2005-06-08 Smokeless toabacco product
US11/571,477 US20080196730A1 (en) 2004-07-02 2005-06-08 Smokeless Tobacco Product

Publications (1)

Publication Number Publication Date
US20080196730A1 true US20080196730A1 (en) 2008-08-21

Family

ID=35783173

Family Applications (1)

Application Number Title Priority Date Filing Date
US11/571,477 Abandoned US20080196730A1 (en) 2004-07-02 2005-06-08 Smokeless Tobacco Product

Country Status (5)

Country Link
US (1) US20080196730A1 (en)
EP (1) EP1765309B1 (en)
AT (1) ATE438390T1 (en)
DE (1) DE602005015854D1 (en)
WO (1) WO2006004480A1 (en)

Cited By (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070012328A1 (en) * 2005-04-29 2007-01-18 Philip Morris Usa Inc. Tobacco pouch product
US20070261707A1 (en) * 2005-04-29 2007-11-15 Philip Morris Usa Inc. Tobacco pouch product
US20080302682A1 (en) * 2007-06-11 2008-12-11 Radi Medical Biodegradable Ab Pouch for tobacco or tobacco substitute
US20090022917A1 (en) * 2007-07-16 2009-01-22 Philip Morris Usa Inc. Oral delivery pouch product with coated seam
US20090035414A1 (en) * 2007-07-16 2009-02-05 Philip Morris Usa Inc. Method of flavor encapsulation through the use of a drum coater
US20100300464A1 (en) * 2008-12-18 2010-12-02 Philip Morris Usa Inc. Moist botanical pouch processing and moist oral botanical pouch products
US20100300463A1 (en) * 2009-06-02 2010-12-02 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US20100300465A1 (en) * 2007-06-08 2010-12-02 Zimmermann Stephen G Oral Pouch Products Including a Liner and Tobacco Beads
US20110048434A1 (en) * 2009-06-02 2011-03-03 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
WO2011087954A1 (en) 2010-01-12 2011-07-21 R. J. Reynolds Tobacco Company Dispensing container
WO2011088171A2 (en) 2010-01-15 2011-07-21 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
US20110180087A1 (en) * 2008-12-30 2011-07-28 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
WO2011127182A1 (en) 2010-04-08 2011-10-13 R. J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
WO2011133633A1 (en) 2010-04-21 2011-10-27 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
US8067046B2 (en) 2007-06-08 2011-11-29 Philip Morris Usa Inc. Oral pouch product including soluble dietary fibers
WO2012021504A2 (en) 2010-08-11 2012-02-16 R. J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US8124147B2 (en) 2007-07-16 2012-02-28 Philip Morris Usa Inc. Oral pouch products with immobilized flavorant particles
WO2012030946A1 (en) 2010-09-02 2012-03-08 R. J. Reynolds Tobacco Company Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method
WO2012033743A1 (en) 2010-09-07 2012-03-15 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US20120067361A1 (en) * 2009-04-03 2012-03-22 X-International Aps Plant fiber product and method for its manufacture
WO2012068375A1 (en) 2010-11-18 2012-05-24 R. J. Reynolds Tobacco Company Fire-cured tobacco extract and tobacco products made therefrom
WO2012075035A2 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
WO2012074985A1 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
WO2012074865A1 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
WO2012083127A1 (en) 2010-12-17 2012-06-21 R. J. Reynolds Tobacco Company Tobacco-derived syrup composition
WO2012103435A1 (en) 2011-01-28 2012-08-02 R. J. Reynolds Tobacco Company Tobacco-derived casing composition
WO2012103327A1 (en) 2011-01-28 2012-08-02 R. J. Reynolds Tobacco Company Polymeric materials derived from tobacco
WO2012106237A1 (en) 2011-01-31 2012-08-09 American Snuff Company, Llc Container for smokeless tobacco products
WO2012148996A1 (en) 2011-04-27 2012-11-01 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
WO2012158915A2 (en) 2011-05-19 2012-11-22 R. J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
WO2013043835A2 (en) 2011-09-22 2013-03-28 R. J. Reynolds Tobacco Company Translucent smokeless tobacco product
US8424541B2 (en) 2007-07-16 2013-04-23 Philip Morris Usa Inc. Tobacco-free oral flavor delivery pouch product
WO2013074903A1 (en) 2011-11-18 2013-05-23 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising tobacco - derived pectin component
WO2013074315A1 (en) 2011-11-17 2013-05-23 R.J. Reynolds Tobacco Company Method for producing triethyl citrate from tobacco
WO2013074742A2 (en) 2011-11-16 2013-05-23 R. J. Reynolds Tobacco Company Smokeless tobacco products with starch component
WO2013090366A2 (en) 2011-12-14 2013-06-20 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
WO2013096408A1 (en) 2011-12-20 2013-06-27 R. J. Reynolds Tobacco Company Meltable smokeless tobacco composition
WO2013119799A1 (en) 2012-02-10 2013-08-15 R. J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
WO2013122948A1 (en) 2012-02-13 2013-08-22 R. J. Reynolds Tobacco Company Whitened tobacco composition
WO2013142483A1 (en) 2012-03-19 2013-09-26 R. J. Reynolds Tobacco Company Method for treating an extracted tobacco pulp and tobacco products made therefrom
WO2013155177A1 (en) 2012-04-11 2013-10-17 R. J. Reynolds Tobacco Company Method for treating plants with probiotics
WO2013158957A1 (en) 2012-04-19 2013-10-24 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
WO2013166285A1 (en) 2012-05-04 2013-11-07 R. J. Reynolds Tobacco Company Transparent moisture barrier coatings for containers
WO2013192519A1 (en) 2012-06-22 2013-12-27 R. J. Reynolds Tobacco Company Composite tobacco-containing materials
US8616221B2 (en) 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
WO2014015228A1 (en) 2012-07-19 2014-01-23 R. J. Reynolds Tobacco Company Method for treating tobacco plants with enzymes
US8685478B2 (en) 2005-11-21 2014-04-01 Philip Morris Usa Inc. Flavor pouch
WO2014058837A1 (en) 2012-10-09 2014-04-17 R. J. Reynolds Tobacco Company Tobacco-derived o-methylated flavonoid composition
US8747562B2 (en) 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
WO2014138223A1 (en) 2013-03-07 2014-09-12 R.J. Reynolds Tobacco Company Method for producing lutein from tobacco
WO2014150926A1 (en) 2013-03-14 2014-09-25 R. J. Reynolds Tobacco Company Sugar-enriched extract derived from tobacco
WO2014159617A1 (en) 2013-03-14 2014-10-02 R. J. Reynolds Tobacco Company Protein-enriched tobacco-derived composition
WO2014165760A1 (en) 2013-04-05 2014-10-09 R. J. Reynolds Tobacco Company Modification of bacterial profile of tobacco
US8863755B2 (en) 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
WO2015017613A1 (en) 2013-08-02 2015-02-05 R.J. Reynolds Tobacco Company Process for producing lignin from tobacco
US8950408B2 (en) 2007-07-16 2015-02-10 Philip Morris Usa Inc. Oral pouch product having soft edge
WO2015021137A1 (en) 2013-08-08 2015-02-12 R. J. Reynolds Tobacco Company Tobacco-derived pyrolysis oil
US8991403B2 (en) 2009-06-02 2015-03-31 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
WO2015077219A2 (en) 2013-11-20 2015-05-28 R. J. Reynolds Tobacco Company Container for smokeless tobacco product
WO2015109085A1 (en) 2014-01-17 2015-07-23 R.J. Reynolds Tobacco Company Process for producing flavorants and related materials
US9126704B2 (en) 2010-04-12 2015-09-08 Altria Client Services Inc. Pouch product with improved seal and method
WO2015183801A1 (en) 2014-05-27 2015-12-03 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US9386800B2 (en) 2012-09-21 2016-07-12 R.J. Reynolds Tobacco Company Fibrous composite tobacco-containing materials
WO2016200804A1 (en) 2015-06-10 2016-12-15 R. J. Reynolds Tobacco Company Container for smokeless tobacco products comprising a pulp material and related packaged product assembly and method
WO2017040785A2 (en) 2015-09-02 2017-03-09 R.J. Reynolds Tobacco Company System and apparatus for reducing tobacco-specific nitrosamines in dark-fire cured tobacco through electronic control of curing conditions
WO2017040789A1 (en) 2015-09-02 2017-03-09 R.J. Reynolds Tobacco Company Method for monitoring use of a tobacco product
US9591875B2 (en) 2012-09-21 2017-03-14 R. J. Reynolds Tobacco Company Fibrous composite tobacco-containing materials
WO2017044466A1 (en) 2015-09-08 2017-03-16 R. J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
WO2017044558A1 (en) 2015-09-09 2017-03-16 R. J. Reynolds Tobacco Company Flavor delivery article
WO2017098439A1 (en) 2015-12-10 2017-06-15 R. J. Reynolds Tobacco Company Protein-enriched tobacco composition
WO2017103795A1 (en) 2015-12-16 2017-06-22 R. J. Reynolds Tobacco Company Flavor additive accessory
WO2017115234A1 (en) 2015-12-28 2017-07-06 R. J. Reynolds Tobacco Company Package for a tobacco-containing material and related packaging method
WO2017120073A1 (en) 2016-01-05 2017-07-13 R.J. Reynolds Tobacco Company Smokeless tobacco product
WO2017130161A1 (en) 2016-01-28 2017-08-03 R. J. Reynolds Tobacco Company Tobacco-derived flavorants
WO2018015872A1 (en) 2016-07-18 2018-01-25 R. J. Reynolds Tobacco Company Nonwoven composite smokeless tobacco product
WO2018109660A2 (en) 2016-12-12 2018-06-21 R. J. Reynolds Tobacco Company Dehydration of tobacco and tobacco-derived materials
US10039311B2 (en) * 2014-10-17 2018-08-07 Securience, LLC Tobacco extract for non-combustible smoking devices
WO2018185708A1 (en) 2017-04-06 2018-10-11 R. J. Reynolds Tobacco Company Smoke treatment
WO2019049049A1 (en) 2017-09-05 2019-03-14 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10329068B2 (en) 2016-05-23 2019-06-25 R.J. Reynolds Tobacco Company Flavoring mechanism for a tobacco related material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2019162903A1 (en) 2018-02-23 2019-08-29 American Snuff Company, Llc Container for smokeless tobacco products
WO2019193580A1 (en) 2018-04-05 2019-10-10 R. J. Reynolds Tobacco Company Oriental tobacco production methods
WO2019198055A2 (en) 2018-04-13 2019-10-17 R. J. Reynolds Tobacco Company Lid for a container for smokeless tobacco products
US10561168B2 (en) 2010-01-15 2020-02-18 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
WO2020128971A1 (en) 2018-12-20 2020-06-25 R. J. Reynolds Tobacco Company Method for whitening tobacco
WO2020225768A1 (en) 2019-05-09 2020-11-12 American Snuff Company, Llc Stabilizer for moist snuff
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
WO2021048770A1 (en) 2019-09-11 2021-03-18 Nicoventures Trading Limited Alternative methods for whitening tobacco
WO2021050741A1 (en) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Oral product with a basic amine and an ion pairing agent
WO2021048769A1 (en) 2019-09-13 2021-03-18 Nicoventures Trading Limited Method for whitening tobacco
WO2021048768A1 (en) 2019-09-11 2021-03-18 Nicoventures Trading Limited Method for whitening tobacco
WO2021048792A1 (en) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Oral product with cellulosic flavor stabilizer
EP3794963A1 (en) 2019-09-18 2021-03-24 American Snuff Company, LLC Method for fermenting tobacco
WO2021086367A1 (en) 2019-10-31 2021-05-06 Nicoventures Trading Limited Oral product and method of manufacture
WO2021116866A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products with enhanced flavor stability
WO2021116822A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with reduced irritation
WO2021116862A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions with reduced water content
WO2021116837A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
WO2021116878A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with improved binding of active ingredients
WO2021116916A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with multiple flavors having different release profiles
WO2021116884A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Layered fleece for pouched product
WO2021116853A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fibrous fleece material
WO2021116890A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Liquid composition for oral use or for use in an aerosol delivery device
WO2021116834A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nanoemulsion for oral use
WO2021116824A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021116841A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Moist oral compositions
WO2021116895A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Stimulus-responsive pouch
WO2021116825A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
WO2021116918A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions including gels
WO2021116894A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2021116876A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with salt inclusion
WO2021116881A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product in a pourous pouch comprising a fleece material
WO2021116891A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral foam composition
WO2021116914A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with polymeric component
WO2021116856A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products
WO2021116887A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Lipid-containing oral composition
WO2021116917A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
WO2021116868A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
WO2021116892A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions with reduced water activity
WO2021116879A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with beet material
WO2021116919A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fleece for oral product with releasable component
WO2021116852A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with dissolvable component
WO2021116854A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with active ingredient combinations
WO2021116893A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product and method of manufacture
WO2021116826A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2021116823A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
WO2021116867A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Buffered oral compositions
WO2021116827A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Process
WO2021116842A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
WO2022043700A1 (en) 2020-08-27 2022-03-03 Nicoventures Trading Limited Oral product
WO2022049536A1 (en) 2020-09-04 2022-03-10 Nicoventures Trading Limited Method for whitening tobacco
WO2022049545A1 (en) 2020-09-04 2022-03-10 Nicoventures Trading Limited Child-resistant container for tobacco-containing products
WO2022053982A1 (en) 2020-09-11 2022-03-17 Nicoventures Trading Limited Alginate-based substrates
US11278050B2 (en) 2017-10-20 2022-03-22 R.J. Reynolds Tobacco Company Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines
WO2022107031A1 (en) 2020-11-19 2022-05-27 Nicoventures Trading Limited Oral products
WO2022112949A1 (en) 2020-11-25 2022-06-02 Nicoventures Trading Limited Oral cannabinoid product with lipid component
WO2022190042A1 (en) 2021-03-12 2022-09-15 Nicoventures Trading Limited Oral products with self-emulsifying system
WO2022189977A1 (en) 2021-03-09 2022-09-15 Nicoventures Trading Limited Oral products and methods of manufacture
WO2022224198A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral lozenge products
WO2022224196A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Orally dissolving films
WO2022224200A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2022224197A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition
WO2022229929A1 (en) 2021-04-30 2022-11-03 Nicoventures Trading Limited Oral products with high-density load
WO2022229926A1 (en) 2021-04-30 2022-11-03 Nicoventures Trading Limited Multi-compartment oral pouched product
WO2022234522A1 (en) 2021-05-06 2022-11-10 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
WO2022264066A1 (en) 2021-06-16 2022-12-22 Nicoventures Trading Limited Pouched product comprising dissolvable composition
WO2022269556A1 (en) 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture
WO2022269475A1 (en) 2021-06-21 2022-12-29 Nicoventures Trading Limited Oral product tablet and method of manufacture
WO2023281469A1 (en) 2021-07-09 2023-01-12 Nicoventures Trading Limited Extruded structures
WO2023002439A1 (en) 2021-07-22 2023-01-26 Nicoventures Trading Limited Nanoemulsion comprising cannabinoid and/or cannabimimetic
WO2023053060A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral gum composition
WO2023053062A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral product with a basic amine and an ion pairing agent
WO2023084499A1 (en) 2021-11-15 2023-05-19 Nicoventures Trading Limited Products with enhanced sensory characteristics
WO2023084498A1 (en) 2021-11-15 2023-05-19 Nicoventures Trading Limited Oral products with nicotine-polymer complex
WO2023194959A1 (en) 2022-04-06 2023-10-12 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2023199282A1 (en) 2022-04-14 2023-10-19 Nicoventures Trading Limited Container for oral products
EP4282779A1 (en) 2014-10-16 2023-11-29 R.J. Reynolds Tobacco Company Package for a tobacco-containing material with a valve assembly and related packaging method
WO2023248187A1 (en) 2022-06-24 2023-12-28 Nicoventures Trading Limited Oral composition comprising a receptor modulator
US11877590B2 (en) 2019-03-27 2024-01-23 Fiedler & Lundgren Ab Smokeless tobacco composition
EP4338735A2 (en) 2015-11-25 2024-03-20 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
WO2024069373A1 (en) 2022-09-26 2024-04-04 Nicoventures Trading Limited Child-resistant container for tobacco-containing products

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
US8469036B2 (en) 2003-11-07 2013-06-25 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2007084587A2 (en) * 2006-01-20 2007-07-26 Monosol Rx, Llc Film lined pouch and method of manufacturing this pouch
US9032971B2 (en) 2006-11-15 2015-05-19 Philip Morris Usa Inc. Moist tobacco product and method of making
US8029837B2 (en) 2007-06-08 2011-10-04 Philip Morris Usa Inc. Chewable pouch for flavored product delivery
WO2009004488A2 (en) 2007-06-08 2009-01-08 Philip Morris Products S.A. Capsule clusters for oral consumption
US8312886B2 (en) 2007-08-09 2012-11-20 Philip Morris Usa Inc. Oral tobacco product having a hydrated membrane coating and a high surface area
US8469037B2 (en) 2008-02-08 2013-06-25 Philip Morris Usa Inc. Pre-portioned moist product and method of making
US20100116281A1 (en) 2008-11-07 2010-05-13 Jerry Wayne Marshall Tobacco products and processes
US9155772B2 (en) 2008-12-08 2015-10-13 Philip Morris Usa Inc. Soft, chewable and orally dissolvable and/or disintegrable products
US9167835B2 (en) 2008-12-30 2015-10-27 Philip Morris Usa Inc. Dissolvable films impregnated with encapsulated tobacco, tea, coffee, botanicals, and flavors for oral products
US9167847B2 (en) 2009-03-16 2015-10-27 Philip Morris Usa Inc. Production of coated tobacco particles suitable for usage in a smokeless tobacoo product
US9848634B2 (en) 2009-06-30 2017-12-26 Philip Morris Products S.A. Smokeless tobacco product
US9687023B2 (en) 2009-10-09 2017-06-27 Philip Morris Usa Inc. Moist smokeless tobacco product for oral usage having on a portion of the outer surface at least one friction reducing strip that provides texture during use
US8539958B2 (en) 2009-10-13 2013-09-24 Philip Morris Usa Inc. Oral moist smokeless tobacco products with net-structured gel coating and methods of making
US8640714B2 (en) 2009-11-12 2014-02-04 Philip Morris Usa Inc. Oral chewable tobacco product and method of manufacture thereof
US8905243B2 (en) 2010-08-11 2014-12-09 R.J. Reynolds Tobacco Company Apparatus for sorting objects, and associated method
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US8931493B2 (en) 2010-11-01 2015-01-13 R.J. Reynolds Tobacco Co. Smokeless tobacco products
US20160044955A1 (en) 2014-08-13 2016-02-18 R.J. Reynolds Tobacco Company Smokeless tobacco products
CN116250483B (en) 2015-06-26 2024-01-30 奥驰亚客户服务公司 Compositions and methods for producing tobacco plants and articles having altered alkaloid content
WO2017192921A1 (en) 2016-05-05 2017-11-09 Monosol Rx, Llc Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation

Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795654A (en) * 1971-12-20 1974-03-05 Union Carbide Corp Degradable polyolefin film
US5167244A (en) * 1990-01-19 1992-12-01 Kjerstad Randy E Tobacco substitute
US5346734A (en) * 1993-04-16 1994-09-13 Bethanie K. Wydick Perforated latex oral pouch for loose snuff
US5540962A (en) * 1992-10-16 1996-07-30 Leonard Pearlstein Degradable package for containment of liquids
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US6041483A (en) * 1997-05-15 2000-03-28 Design Cast Studios Llc Funerary urn
US6162516A (en) * 1995-10-11 2000-12-19 Derr; Dedric M. System and method for protecting oral tissues from smokeless tobacco
US20030118692A1 (en) * 2001-10-22 2003-06-26 Yadong Wang Biodegradable polymer
US6670521B2 (en) * 2000-04-20 2003-12-30 The Procter & Gamble Company Dispersible absorbent products and methods of manufacture and use
US20040178104A1 (en) * 2001-05-22 2004-09-16 Uni-Charm Corporation Interlabial pad individual packaging body
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US20050136155A1 (en) * 2003-12-22 2005-06-23 Jordan Joy F. Specialty beverage infusion package
US7021848B1 (en) * 1999-10-08 2006-04-04 The Procter & Gamble Company Semi-enclosed applicator having a temperature changing element
US20060260973A1 (en) * 2003-06-20 2006-11-23 Plantic Technologies Ltd. Easy open water soluble blister package
US20070012328A1 (en) * 2005-04-29 2007-01-18 Philip Morris Usa Inc. Tobacco pouch product
US20070031539A1 (en) * 2005-08-02 2007-02-08 Calton Jim S Jr Personal caffeine delivery pouch
US20070062549A1 (en) * 2005-09-22 2007-03-22 Holton Darrell E Jr Smokeless tobacco composition
US20070186941A1 (en) * 2006-02-10 2007-08-16 Holton Darrell E Jr Smokeless tobacco composition
US20080029116A1 (en) * 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
US20080302682A1 (en) * 2007-06-11 2008-12-11 Radi Medical Biodegradable Ab Pouch for tobacco or tobacco substitute

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855326A (en) * 1987-04-20 1989-08-08 Fuisz Pharmaceutical Ltd. Rapidly dissoluble medicinal dosage unit and method of manufacture
AU5751799A (en) * 1998-09-09 2000-03-27 Quadrant Holdings Cambridge Limited Filamentous amorphous carbohydrate compositions and therapeutic delivery vehicles comprising them
DE10157124A1 (en) * 2001-11-21 2003-05-28 Lohmann Therapie Syst Lts Controlled release device useful for e.g. oral or transdermal administration of pharmaceuticals comprises a microfiber including releasable active material
ATE353633T1 (en) * 2002-12-19 2007-03-15 Pharmacia Corp NON-HYGROSCOPIC FORMULATION CONTAINING A HYGROSCOPIC ACTIVE INGREDIENT

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3795654A (en) * 1971-12-20 1974-03-05 Union Carbide Corp Degradable polyolefin film
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5167244A (en) * 1990-01-19 1992-12-01 Kjerstad Randy E Tobacco substitute
US5540962A (en) * 1992-10-16 1996-07-30 Leonard Pearlstein Degradable package for containment of liquids
US5346734A (en) * 1993-04-16 1994-09-13 Bethanie K. Wydick Perforated latex oral pouch for loose snuff
US6162516A (en) * 1995-10-11 2000-12-19 Derr; Dedric M. System and method for protecting oral tissues from smokeless tobacco
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6041483A (en) * 1997-05-15 2000-03-28 Design Cast Studios Llc Funerary urn
US7021848B1 (en) * 1999-10-08 2006-04-04 The Procter & Gamble Company Semi-enclosed applicator having a temperature changing element
US6670521B2 (en) * 2000-04-20 2003-12-30 The Procter & Gamble Company Dispersible absorbent products and methods of manufacture and use
US20040178104A1 (en) * 2001-05-22 2004-09-16 Uni-Charm Corporation Interlabial pad individual packaging body
US20030118692A1 (en) * 2001-10-22 2003-06-26 Yadong Wang Biodegradable polymer
US20060260973A1 (en) * 2003-06-20 2006-11-23 Plantic Technologies Ltd. Easy open water soluble blister package
US20050136112A1 (en) * 2003-12-19 2005-06-23 Pediamed Pharmaceuticals, Inc. Oral medicament delivery system
US20050136155A1 (en) * 2003-12-22 2005-06-23 Jordan Joy F. Specialty beverage infusion package
US20070012328A1 (en) * 2005-04-29 2007-01-18 Philip Morris Usa Inc. Tobacco pouch product
US20070031539A1 (en) * 2005-08-02 2007-02-08 Calton Jim S Jr Personal caffeine delivery pouch
US20070062549A1 (en) * 2005-09-22 2007-03-22 Holton Darrell E Jr Smokeless tobacco composition
US20070186941A1 (en) * 2006-02-10 2007-08-16 Holton Darrell E Jr Smokeless tobacco composition
US20080029116A1 (en) * 2006-08-01 2008-02-07 John Howard Robinson Smokeless tobacco
US20080302682A1 (en) * 2007-06-11 2008-12-11 Radi Medical Biodegradable Ab Pouch for tobacco or tobacco substitute

Cited By (234)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8678015B2 (en) 2005-04-29 2014-03-25 Philip Morris Usa Inc. Non-tobacco pouch product
US20070261707A1 (en) * 2005-04-29 2007-11-15 Philip Morris Usa Inc. Tobacco pouch product
US20070012328A1 (en) * 2005-04-29 2007-01-18 Philip Morris Usa Inc. Tobacco pouch product
US20110203601A1 (en) * 2005-04-29 2011-08-25 Philip Morris Usa Inc. Non-tobacco pouch product
US9044049B2 (en) 2005-04-29 2015-06-02 Philip Morris Usa Inc. Tobacco pouch product
US8671952B2 (en) 2005-04-29 2014-03-18 Philip Morris Usa Inc. Tobacco pouch product
US7980251B2 (en) 2005-04-29 2011-07-19 Philip Morris Usa Inc. Method of making pouched tobacco product
US7950399B2 (en) 2005-04-29 2011-05-31 Philip Morris Usa Inc. Non-tobacco pouch product
US9139360B2 (en) 2005-11-21 2015-09-22 Philip Morris Usa Inc. Flavor pouch
US8685478B2 (en) 2005-11-21 2014-04-01 Philip Morris Usa Inc. Flavor pouch
US9643773B2 (en) 2005-11-21 2017-05-09 Philip Morris Usa Inc. Flavor pouch
US10065794B2 (en) 2005-11-21 2018-09-04 Philip Morris Usa Inc. Flavor pouch
US9345267B2 (en) 2007-02-28 2016-05-24 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US8616221B2 (en) 2007-02-28 2013-12-31 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US9061824B2 (en) 2007-02-28 2015-06-23 Philip Morris Usa Inc. Oral pouch product with flavored wrapper
US20100300465A1 (en) * 2007-06-08 2010-12-02 Zimmermann Stephen G Oral Pouch Products Including a Liner and Tobacco Beads
US8067046B2 (en) 2007-06-08 2011-11-29 Philip Morris Usa Inc. Oral pouch product including soluble dietary fibers
US9888712B2 (en) 2007-06-08 2018-02-13 Philip Morris Usa Inc. Oral pouch products including a liner and tobacco beads
US20080302682A1 (en) * 2007-06-11 2008-12-11 Radi Medical Biodegradable Ab Pouch for tobacco or tobacco substitute
US11542049B2 (en) 2007-07-16 2023-01-03 Philip Morris Usa Inc. Oral pouch product having soft edge and method of making
US8202589B2 (en) 2007-07-16 2012-06-19 Philip Morris Usa Inc. Oral delivery pouch product with coated seam
US8124147B2 (en) 2007-07-16 2012-02-28 Philip Morris Usa Inc. Oral pouch products with immobilized flavorant particles
US9889956B2 (en) 2007-07-16 2018-02-13 Philip Morris Usa Inc. Oral pouch product having soft edge and method of making
US20090022917A1 (en) * 2007-07-16 2009-01-22 Philip Morris Usa Inc. Oral delivery pouch product with coated seam
US8950408B2 (en) 2007-07-16 2015-02-10 Philip Morris Usa Inc. Oral pouch product having soft edge
US8424541B2 (en) 2007-07-16 2013-04-23 Philip Morris Usa Inc. Tobacco-free oral flavor delivery pouch product
US10640246B2 (en) 2007-07-16 2020-05-05 Philip Morris Usa Inc. Oral pouch product having soft edge and method of making
US20090035414A1 (en) * 2007-07-16 2009-02-05 Philip Morris Usa Inc. Method of flavor encapsulation through the use of a drum coater
US8701679B2 (en) 2007-07-16 2014-04-22 Philip Morris Usa Inc. Tobacco-free oral flavor delivery pouch product
US8119173B2 (en) 2007-07-16 2012-02-21 Philip Morris Usa Inc. Method of flavor encapsulation through the use of a drum coater
US10492523B2 (en) 2008-12-17 2019-12-03 Philip Morris Usa Inc. Moist botanical pouch processing and moist oral botanical pouch products
US8377215B2 (en) 2008-12-18 2013-02-19 Philip Morris Usa Inc. Moist botanical pouch processing
US20100300464A1 (en) * 2008-12-18 2010-12-02 Philip Morris Usa Inc. Moist botanical pouch processing and moist oral botanical pouch products
US9516894B2 (en) 2008-12-18 2016-12-13 Philip Morris Usa Inc. Moist botanical pouch processing and moist oral botanical pouch products
US20110180087A1 (en) * 2008-12-30 2011-07-28 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US9027567B2 (en) 2008-12-30 2015-05-12 Philip Morris Usa Inc. Oral pouch product with multi-layered pouch wrapper
US8863755B2 (en) 2009-02-27 2014-10-21 Philip Morris Usa Inc. Controlled flavor release tobacco pouch products and methods of making
US20120067361A1 (en) * 2009-04-03 2012-03-22 X-International Aps Plant fiber product and method for its manufacture
US8944072B2 (en) 2009-06-02 2015-02-03 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US20100300463A1 (en) * 2009-06-02 2010-12-02 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US20110048434A1 (en) * 2009-06-02 2011-03-03 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US8434496B2 (en) 2009-06-02 2013-05-07 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US8991403B2 (en) 2009-06-02 2015-03-31 R.J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
US10143230B2 (en) 2009-10-09 2018-12-04 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
US8747562B2 (en) 2009-10-09 2014-06-10 Philip Morris Usa Inc. Tobacco-free pouched product containing flavor beads providing immediate and long lasting flavor release
WO2011087954A1 (en) 2010-01-12 2011-07-21 R. J. Reynolds Tobacco Company Dispensing container
US10561168B2 (en) 2010-01-15 2020-02-18 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
US8955523B2 (en) 2010-01-15 2015-02-17 R.J. Reynolds Tobacco Company Tobacco-derived components and materials
WO2011088171A2 (en) 2010-01-15 2011-07-21 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
WO2011127182A1 (en) 2010-04-08 2011-10-13 R. J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
US9039839B2 (en) 2010-04-08 2015-05-26 R.J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
US10342251B2 (en) 2010-04-08 2019-07-09 R.J. Reynolds Tobacco Company Smokeless tobacco composition comprising tobacco-derived material and non-tobacco plant material
US9820507B2 (en) 2010-04-12 2017-11-21 Altria Client Services Llc Method of making oral pouch product
US9126704B2 (en) 2010-04-12 2015-09-08 Altria Client Services Inc. Pouch product with improved seal and method
WO2011133633A1 (en) 2010-04-21 2011-10-27 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
US10028522B2 (en) 2010-04-21 2018-07-24 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
US9402415B2 (en) 2010-04-21 2016-08-02 R. J. Reynolds Tobacco Company Tobacco seed-derived components and materials
US11666083B2 (en) 2010-08-11 2023-06-06 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
WO2012021504A2 (en) 2010-08-11 2012-02-16 R. J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US10772350B2 (en) 2010-08-11 2020-09-15 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US11116237B2 (en) 2010-08-11 2021-09-14 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US9155321B2 (en) 2010-08-11 2015-10-13 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
US9993020B2 (en) 2010-08-11 2018-06-12 R.J. Reynolds Tobacco Company Meltable smokeless tobacco composition
WO2012021683A2 (en) 2010-08-12 2012-02-16 R. J. Reynolds Tobacco Company Thermal treatment process for tobacco materials
WO2012030946A1 (en) 2010-09-02 2012-03-08 R. J. Reynolds Tobacco Company Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method
US11172702B2 (en) 2010-09-02 2021-11-16 R. J. Reynolds Tobacco Company Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method
US10028520B2 (en) 2010-09-02 2018-07-24 R.J. Reynolds Tobacco Company Apparatus for manufacturing a smokeless tobacco product incorporating an object, and associated method
US9675102B2 (en) 2010-09-07 2017-06-13 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US10537132B2 (en) 2010-09-07 2020-01-21 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
WO2012033743A1 (en) 2010-09-07 2012-03-15 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
WO2012068375A1 (en) 2010-11-18 2012-05-24 R. J. Reynolds Tobacco Company Fire-cured tobacco extract and tobacco products made therefrom
WO2012074865A1 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
WO2012075035A2 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
WO2012074985A1 (en) 2010-12-01 2012-06-07 R. J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
US9220295B2 (en) 2010-12-01 2015-12-29 R.J. Reynolds Tobacco Company Tobacco separation process for extracting tobacco-derived materials, and associated extraction systems
US9775376B2 (en) 2010-12-01 2017-10-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and moulding process for forming smokeless tobacco products
US9204667B2 (en) 2010-12-01 2015-12-08 R.J. Reynolds Tobacco Company Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products
WO2012083127A1 (en) 2010-12-17 2012-06-21 R. J. Reynolds Tobacco Company Tobacco-derived syrup composition
WO2012103435A1 (en) 2011-01-28 2012-08-02 R. J. Reynolds Tobacco Company Tobacco-derived casing composition
US9107453B2 (en) 2011-01-28 2015-08-18 R.J. Reynolds Tobacco Company Tobacco-derived casing composition
WO2012103327A1 (en) 2011-01-28 2012-08-02 R. J. Reynolds Tobacco Company Polymeric materials derived from tobacco
US10159273B2 (en) 2011-01-28 2018-12-25 R.J. Reynolds Tobacco Company Tobacco-derived casing composition
WO2012106237A1 (en) 2011-01-31 2012-08-09 American Snuff Company, Llc Container for smokeless tobacco products
WO2012148996A1 (en) 2011-04-27 2012-11-01 R. J. Reynolds Tobacco Company Tobacco-derived components and materials
EP3545775A1 (en) 2011-04-27 2019-10-02 R. J. Reynolds Tobacco Company Method of extracting and isolating compounds from plants of the nicotiana species useful as flavor material
WO2012158915A2 (en) 2011-05-19 2012-11-22 R. J. Reynolds Tobacco Company Molecularly imprinted polymers for treating tobacco material and filtering smoke from smoking articles
WO2013043835A2 (en) 2011-09-22 2013-03-28 R. J. Reynolds Tobacco Company Translucent smokeless tobacco product
WO2013074742A2 (en) 2011-11-16 2013-05-23 R. J. Reynolds Tobacco Company Smokeless tobacco products with starch component
EP3954229A1 (en) 2011-11-16 2022-02-16 R. J. Reynolds Tobacco Company Smokeless tobacco products with starch component
WO2013074315A1 (en) 2011-11-17 2013-05-23 R.J. Reynolds Tobacco Company Method for producing triethyl citrate from tobacco
WO2013074903A1 (en) 2011-11-18 2013-05-23 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising tobacco - derived pectin component
WO2013090366A2 (en) 2011-12-14 2013-06-20 R. J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US11918027B2 (en) 2011-12-14 2024-03-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
US10881132B2 (en) 2011-12-14 2021-01-05 R.J. Reynolds Tobacco Company Smokeless tobacco product comprising effervescent composition
WO2013096408A1 (en) 2011-12-20 2013-06-27 R. J. Reynolds Tobacco Company Meltable smokeless tobacco composition
EP3782474A1 (en) 2011-12-20 2021-02-24 R. J. Reynolds Tobacco Company Meltable smokeless tobacco composition
WO2013119799A1 (en) 2012-02-10 2013-08-15 R. J. Reynolds Tobacco Company Multi-layer smokeless tobacco composition
EP3461351A1 (en) 2012-02-13 2019-04-03 R. J. Reynolds Tobacco Company Whitend tobacco composition
WO2013122948A1 (en) 2012-02-13 2013-08-22 R. J. Reynolds Tobacco Company Whitened tobacco composition
WO2013142483A1 (en) 2012-03-19 2013-09-26 R. J. Reynolds Tobacco Company Method for treating an extracted tobacco pulp and tobacco products made therefrom
EP3398457A1 (en) 2012-04-11 2018-11-07 R. J. Reynolds Tobacco Company Method for treating plants with probiotics
WO2013155177A1 (en) 2012-04-11 2013-10-17 R. J. Reynolds Tobacco Company Method for treating plants with probiotics
WO2013158957A1 (en) 2012-04-19 2013-10-24 R. J. Reynolds Tobacco Company Method for producing microcrystalline cellulose from tobacco and related tobacco product
WO2013166285A1 (en) 2012-05-04 2013-11-07 R. J. Reynolds Tobacco Company Transparent moisture barrier coatings for containers
WO2013192519A1 (en) 2012-06-22 2013-12-27 R. J. Reynolds Tobacco Company Composite tobacco-containing materials
US11490650B2 (en) 2012-06-22 2022-11-08 R.J. Reynolds Tobacco Company Composite tobacco-containing materials
WO2014015228A1 (en) 2012-07-19 2014-01-23 R. J. Reynolds Tobacco Company Method for treating tobacco plants with enzymes
US9591875B2 (en) 2012-09-21 2017-03-14 R. J. Reynolds Tobacco Company Fibrous composite tobacco-containing materials
US9386800B2 (en) 2012-09-21 2016-07-12 R.J. Reynolds Tobacco Company Fibrous composite tobacco-containing materials
WO2014058837A1 (en) 2012-10-09 2014-04-17 R. J. Reynolds Tobacco Company Tobacco-derived o-methylated flavonoid composition
WO2014138223A1 (en) 2013-03-07 2014-09-12 R.J. Reynolds Tobacco Company Method for producing lutein from tobacco
WO2014150926A1 (en) 2013-03-14 2014-09-25 R. J. Reynolds Tobacco Company Sugar-enriched extract derived from tobacco
WO2014159617A1 (en) 2013-03-14 2014-10-02 R. J. Reynolds Tobacco Company Protein-enriched tobacco-derived composition
WO2014165760A1 (en) 2013-04-05 2014-10-09 R. J. Reynolds Tobacco Company Modification of bacterial profile of tobacco
WO2015017613A1 (en) 2013-08-02 2015-02-05 R.J. Reynolds Tobacco Company Process for producing lignin from tobacco
WO2015021137A1 (en) 2013-08-08 2015-02-12 R. J. Reynolds Tobacco Company Tobacco-derived pyrolysis oil
US11503853B2 (en) 2013-09-09 2022-11-22 R.J. Reynolds Tobacco Company Smokeless tobacco composition incorporating a botanical material
US10357054B2 (en) 2013-10-16 2019-07-23 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US10568355B2 (en) 2013-10-16 2020-02-25 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US11540555B2 (en) 2013-10-16 2023-01-03 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
US10980271B2 (en) 2013-10-16 2021-04-20 R.J. Reynolds Tobacco Company Smokeless tobacco pastille
WO2015077219A2 (en) 2013-11-20 2015-05-28 R. J. Reynolds Tobacco Company Container for smokeless tobacco product
WO2015109085A1 (en) 2014-01-17 2015-07-23 R.J. Reynolds Tobacco Company Process for producing flavorants and related materials
WO2015183801A1 (en) 2014-05-27 2015-12-03 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP3871515A1 (en) 2014-05-27 2021-09-01 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
EP4282779A1 (en) 2014-10-16 2023-11-29 R.J. Reynolds Tobacco Company Package for a tobacco-containing material with a valve assembly and related packaging method
US10039311B2 (en) * 2014-10-17 2018-08-07 Securience, LLC Tobacco extract for non-combustible smoking devices
US10881133B2 (en) 2015-04-16 2021-01-05 R.J. Reynolds Tobacco Company Tobacco-derived cellulosic sugar
WO2016200804A1 (en) 2015-06-10 2016-12-15 R. J. Reynolds Tobacco Company Container for smokeless tobacco products comprising a pulp material and related packaged product assembly and method
WO2017040789A1 (en) 2015-09-02 2017-03-09 R.J. Reynolds Tobacco Company Method for monitoring use of a tobacco product
WO2017040785A2 (en) 2015-09-02 2017-03-09 R.J. Reynolds Tobacco Company System and apparatus for reducing tobacco-specific nitrosamines in dark-fire cured tobacco through electronic control of curing conditions
WO2017044466A1 (en) 2015-09-08 2017-03-16 R. J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
US10869497B2 (en) 2015-09-08 2020-12-22 R.J. Reynolds Tobacco Company High-pressure cold pasteurization of tobacco material
WO2017044558A1 (en) 2015-09-09 2017-03-16 R. J. Reynolds Tobacco Company Flavor delivery article
EP4338735A2 (en) 2015-11-25 2024-03-20 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
WO2017098439A1 (en) 2015-12-10 2017-06-15 R. J. Reynolds Tobacco Company Protein-enriched tobacco composition
US11612183B2 (en) 2015-12-10 2023-03-28 R.J. Reynolds Tobacco Company Protein-enriched tobacco composition
WO2017103795A1 (en) 2015-12-16 2017-06-22 R. J. Reynolds Tobacco Company Flavor additive accessory
WO2017115234A1 (en) 2015-12-28 2017-07-06 R. J. Reynolds Tobacco Company Package for a tobacco-containing material and related packaging method
WO2017120073A1 (en) 2016-01-05 2017-07-13 R.J. Reynolds Tobacco Company Smokeless tobacco product
US10499684B2 (en) 2016-01-28 2019-12-10 R.J. Reynolds Tobacco Company Tobacco-derived flavorants
WO2017130161A1 (en) 2016-01-28 2017-08-03 R. J. Reynolds Tobacco Company Tobacco-derived flavorants
US10329068B2 (en) 2016-05-23 2019-06-25 R.J. Reynolds Tobacco Company Flavoring mechanism for a tobacco related material
US10375984B2 (en) 2016-07-18 2019-08-13 R.J. Reynolds Tobacco Company Nonwoven composite smokeless tobacco product
US10588338B2 (en) 2016-07-18 2020-03-17 R.J. Reynolds Tobacco Company Nonwoven composite smokeless tobacco product
WO2018015872A1 (en) 2016-07-18 2018-01-25 R. J. Reynolds Tobacco Company Nonwoven composite smokeless tobacco product
WO2018109660A2 (en) 2016-12-12 2018-06-21 R. J. Reynolds Tobacco Company Dehydration of tobacco and tobacco-derived materials
US11891364B2 (en) 2017-03-24 2024-02-06 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
US11091446B2 (en) 2017-03-24 2021-08-17 R.J. Reynolds Tobacco Company Methods of selectively forming substituted pyrazines
WO2018185708A1 (en) 2017-04-06 2018-10-11 R. J. Reynolds Tobacco Company Smoke treatment
WO2019049049A1 (en) 2017-09-05 2019-03-14 R. J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US11278050B2 (en) 2017-10-20 2022-03-22 R.J. Reynolds Tobacco Company Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines
WO2019162903A1 (en) 2018-02-23 2019-08-29 American Snuff Company, Llc Container for smokeless tobacco products
WO2019193580A1 (en) 2018-04-05 2019-10-10 R. J. Reynolds Tobacco Company Oriental tobacco production methods
WO2019198055A2 (en) 2018-04-13 2019-10-17 R. J. Reynolds Tobacco Company Lid for a container for smokeless tobacco products
WO2020128971A1 (en) 2018-12-20 2020-06-25 R. J. Reynolds Tobacco Company Method for whitening tobacco
US11877590B2 (en) 2019-03-27 2024-01-23 Fiedler & Lundgren Ab Smokeless tobacco composition
US11213062B2 (en) 2019-05-09 2022-01-04 American Snuff Company Stabilizer for moist snuff
WO2020225768A1 (en) 2019-05-09 2020-11-12 American Snuff Company, Llc Stabilizer for moist snuff
WO2021048791A1 (en) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Pouched products with enhanced flavor stability
WO2021048792A1 (en) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Oral product with cellulosic flavor stabilizer
WO2021048768A1 (en) 2019-09-11 2021-03-18 Nicoventures Trading Limited Method for whitening tobacco
WO2021050741A1 (en) 2019-09-11 2021-03-18 R. J. Reynolds Tobacco Company Oral product with a basic amine and an ion pairing agent
WO2021048770A1 (en) 2019-09-11 2021-03-18 Nicoventures Trading Limited Alternative methods for whitening tobacco
EP4285743A2 (en) 2019-09-11 2023-12-06 Nicoventures Trading Limited Oral product with a basic amine and an ion pairing agent
WO2021048769A1 (en) 2019-09-13 2021-03-18 Nicoventures Trading Limited Method for whitening tobacco
EP3794963A1 (en) 2019-09-18 2021-03-24 American Snuff Company, LLC Method for fermenting tobacco
WO2021086367A1 (en) 2019-10-31 2021-05-06 Nicoventures Trading Limited Oral product and method of manufacture
WO2021116876A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with salt inclusion
WO2021116825A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
WO2021116856A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products
WO2021116887A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Lipid-containing oral composition
WO2021116917A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with nanocrystalline cellulose
WO2021116868A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
WO2021116892A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions with reduced water activity
WO2021116879A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with beet material
WO2021116919A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fleece for oral product with releasable component
WO2021116852A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with dissolvable component
WO2021116854A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with active ingredient combinations
WO2021116893A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product and method of manufacture
WO2021116826A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021116855A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2021116823A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product
WO2021116867A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Buffered oral compositions
WO2021116827A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Process
WO2021116842A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with controlled release
WO2021116891A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral foam composition
WO2021116881A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product in a pourous pouch comprising a fleece material
WO2021116894A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2021116918A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions including gels
WO2021116853A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Fibrous fleece material
WO2021116890A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Liquid composition for oral use or for use in an aerosol delivery device
WO2021116895A2 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Stimulus-responsive pouch
WO2021116884A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Layered fleece for pouched product
WO2021116834A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Nanoemulsion for oral use
WO2021116916A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product with multiple flavors having different release profiles
WO2021116824A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral product comprising a cannabinoid
WO2021116841A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Moist oral compositions
WO2021116878A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with improved binding of active ingredients
WO2021116865A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Agents for oral composition
WO2021116914A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral composition with polymeric component
WO2021116837A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products
WO2021116866A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Pouched products with enhanced flavor stability
WO2021116822A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral products with reduced irritation
WO2021116862A1 (en) 2019-12-09 2021-06-17 Nicoventures Trading Limited Oral compositions with reduced water content
WO2021250516A1 (en) 2020-06-08 2021-12-16 Nicoventures Trading Limited Effervescent oral composition comprising an active ingredient
WO2022043700A1 (en) 2020-08-27 2022-03-03 Nicoventures Trading Limited Oral product
WO2022049545A1 (en) 2020-09-04 2022-03-10 Nicoventures Trading Limited Child-resistant container for tobacco-containing products
WO2022049536A1 (en) 2020-09-04 2022-03-10 Nicoventures Trading Limited Method for whitening tobacco
WO2022053982A1 (en) 2020-09-11 2022-03-17 Nicoventures Trading Limited Alginate-based substrates
WO2022107031A1 (en) 2020-11-19 2022-05-27 Nicoventures Trading Limited Oral products
WO2022112949A1 (en) 2020-11-25 2022-06-02 Nicoventures Trading Limited Oral cannabinoid product with lipid component
WO2022189977A1 (en) 2021-03-09 2022-09-15 Nicoventures Trading Limited Oral products and methods of manufacture
WO2022190042A1 (en) 2021-03-12 2022-09-15 Nicoventures Trading Limited Oral products with self-emulsifying system
WO2022224198A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral lozenge products
WO2022224196A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Orally dissolving films
WO2022224200A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Oral compositions and methods of manufacture
WO2022224197A1 (en) 2021-04-22 2022-10-27 Nicoventures Trading Limited Effervescent oral composition
WO2022229926A1 (en) 2021-04-30 2022-11-03 Nicoventures Trading Limited Multi-compartment oral pouched product
WO2022229929A1 (en) 2021-04-30 2022-11-03 Nicoventures Trading Limited Oral products with high-density load
WO2022234522A1 (en) 2021-05-06 2022-11-10 Nicoventures Trading Limited Oral compositions and related methods for reducing throat irritation
WO2022264066A1 (en) 2021-06-16 2022-12-22 Nicoventures Trading Limited Pouched product comprising dissolvable composition
WO2022269475A1 (en) 2021-06-21 2022-12-29 Nicoventures Trading Limited Oral product tablet and method of manufacture
WO2022269556A1 (en) 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture
WO2023281469A1 (en) 2021-07-09 2023-01-12 Nicoventures Trading Limited Extruded structures
WO2023002439A1 (en) 2021-07-22 2023-01-26 Nicoventures Trading Limited Nanoemulsion comprising cannabinoid and/or cannabimimetic
WO2023053060A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral gum composition
WO2023053062A1 (en) 2021-09-30 2023-04-06 Nicoventures Trading Limited Oral product with a basic amine and an ion pairing agent
WO2023084498A1 (en) 2021-11-15 2023-05-19 Nicoventures Trading Limited Oral products with nicotine-polymer complex
WO2023084499A1 (en) 2021-11-15 2023-05-19 Nicoventures Trading Limited Products with enhanced sensory characteristics
WO2023194959A1 (en) 2022-04-06 2023-10-12 Nicoventures Trading Limited Pouched products with heat sealable binder
WO2023199282A1 (en) 2022-04-14 2023-10-19 Nicoventures Trading Limited Container for oral products
WO2023248187A1 (en) 2022-06-24 2023-12-28 Nicoventures Trading Limited Oral composition comprising a receptor modulator
WO2024069373A1 (en) 2022-09-26 2024-04-04 Nicoventures Trading Limited Child-resistant container for tobacco-containing products

Also Published As

Publication number Publication date
EP1765309A1 (en) 2007-03-28
WO2006004480A1 (en) 2006-01-12
EP1765309B1 (en) 2009-08-05
DE602005015854D1 (en) 2009-09-17
ATE438390T1 (en) 2009-08-15

Similar Documents

Publication Publication Date Title
EP1765309B1 (en) Smokeless toabacco product
EP0749278B1 (en) Nicotine oral delivery device
EP2405942B1 (en) Oral delivery product
JP5283334B2 (en) Composition material for transmucosal transmission
JP5845194B2 (en) Nicotine-containing soft gelatin troche
WO2014093127A2 (en) Enhanced delivery of nicotine, thc, tobacco, cannabidiol or base alkaloid from an electronic cigarette or other vapor or smoke producing device through use of an absorption conditioning unit
US20080166395A1 (en) Article for delivering substrates to the oral cavity
US20140166027A1 (en) Enhanced Delivery of Nicotine, THC, Tobacco, Cannabidiol or Base Alkaloid from an Electronic Cigarette or Other Vapor Producing Device Through Use of an Absorption Conditioning Unit
US20050034738A1 (en) Chewing tobacco substitute containing nicotine
JP2009527488A (en) Degradable oral film
DE602004017127D1 (en) LONG-TERM, AROMATED PHARMACEUTICAL FOR THE EXTENDED RELEASE OF ACTIVE SUBSTANCES IN THE MOUTH
US20060112965A1 (en) Chewing tobacco substitute containing cotinine
US20100256197A1 (en) Nicotine Dissolving Film With Or Without Menthol
BRPI0711996A2 (en) Pharmaceutical preparation in the form of a sheet, Use of the pharmaceutical preparation, Use of a combination of active agents, Method for the therapeutic treatment of an individual and Method for the production of a dosage form
CN1871953B (en) Cigarette with tea smell
US20080017205A1 (en) Method and Device for Releasing Flavor and Odor Substances
JPH01197435A (en) Plaster substituting smoking
US20140271847A1 (en) Formulations and methods for rapid penile erections
KR100332840B1 (en) The Antismoking Aid containing an Artemisia
CN1741791B (en) A composition material for transmucosal delivery
CN106714815A (en) Homeopathy preparation for promoting smoker to stop smoking
WO2001080672A1 (en) Method of reducing or quitting smoking
CN103040089B (en) Oral product
US20120132218A1 (en) Smokeless tobacco cessation product
Zuccaroli et al. How to stop smoking: OTC management

Legal Events

Date Code Title Description
AS Assignment

Owner name: RADI MEDICAL SYSTEMS AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ENGSTROM, THOMAS;MATHISEN, TORBJORN;REEL/FRAME:018852/0336

Effective date: 20070108

AS Assignment

Owner name: RADI MEDICAL BIODEGRADABLE AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RADI MEDICAL SYSTEMS AB;REEL/FRAME:019294/0492

Effective date: 20070507

AS Assignment

Owner name: IDAR MEDICAL BIODEGRADABLE AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:RADI MEDICAL BIODEGRADABLE AB;REEL/FRAME:022695/0859

Effective date: 20090210

AS Assignment

Owner name: NOVUS SCIENTIFIC PTE. LTD., SINGAPORE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IDAR MEDICAL BIODEGRADABLE AB;REEL/FRAME:023851/0795

Effective date: 20091214

Owner name: NOVUS SCIENTIFIC PTE. LTD.,SINGAPORE

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IDAR MEDICAL BIODEGRADABLE AB;REEL/FRAME:023851/0795

Effective date: 20091214

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: NOVUS SCIENTIFIC AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NOVUS SCIENTIFIC PTE. LTD.;REEL/FRAME:030990/0007

Effective date: 20130722